FDA approves blood test to help detect Alzheimer’s disease in people 55 and older
The test measures p-tau217, a biomarker linked to Alzheimer’s, and can return positive, intermediate or negative results to aid clinical evaluation.
The test measures p-tau217, a biomarker linked to Alzheimer’s, and can return positive, intermediate or negative results to aid clinical evaluation.
What's Your Reaction?
